China Considers Uniform Pricing For EDL Meds
This article was originally published in PharmAsia News
China’s State FDA will pilot adjustable uniform prices for essential drugs based on their manufacturing costs and reasonable profits for drugmakers.
You may also be interested in...
France has announced a number of emergency measures to protect drug supplies threatened by the spread of the coronavirus.
Major generics companies have donated hydroxychloroquine sulfate doses for research and treatment of coronavirus. Companies are also donating hand sanitizer and personal protective equipment and are preparing to ramp up manufacturing and production.
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?